EcoR1 Capital, LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 6:22 pm Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | EcoR1 Capital, LLC | 1,250,385 1.300% | -2,242,809![]() (-64.21%) | Filing |
2022-09-26 4:06 pm Purchase | 2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX | EcoR1 Capital, LLC | 3,493,194 5.500% | 3,493,194![]() (New Position) | Filing |